Evidence map›Paper›PMID 29416200›Full record

ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2017

Hyperlactatemia and the Importance of Repeated Lactate Measurements in Critically Ill Patients.

Amina Godinjak, Selma Jusufovic, Admir Rama, Amer Iglica, Faris Zvizdic, Adis Kukuljac, Ira Tancica, Sejla Rozajac

Open access · greenAbstract read
In one paragraph

Article in Medical archives (Sarajevo, Bosnia and Herzegovina), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Linezolid-induced lactic acidosis.BMJ case reports · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Amina GodinjakClinic for Emergency Medicine, Clinical Center University of Sarajevo, Bosnia and Herzegovina.
Selma JusufovicClinic for Nuclear Medicine and Endocrinology, Clinical Center University of Sarajevo, Bosnia and Herzegovina.
Admir RamaBahceci IVF Center Sarajevo, Bosnia and Herzegovina.
Amer IglicaClinic for Heart, Vascular diseases and Rheumatology, Clinical Center University of Sarajevo, Bosnia and Herzegovina.
Faris ZvizdicClinic for Heart, Vascular diseases and Rheumatology, Clinical Center University of Sarajevo, Bosnia and Herzegovina.
Adis KukuljacMedical High School Jezero, Sarajevo, Bosnia and Herzegovina.
Ira TancicaClinic for Gastroenterohepatology, Clinical Center University of Sarajevo, Bosnia and Herzegovina.
Sejla RozajacPrimary Health care Center Fojnica, Fojnica, Bosnia and Herzegovina.
Clinical Center University of Sarajevo · BAUniversity of Sarajevo · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of the study was to describe the prevalence of hyperlactatemia and emphasis on repeated lactate measurements in critically ill patients, and the associated mortality. MATERIALS AND

methodsThe study included 70 patients admitted in the Medical Intensive Care Unit at the Clinical Center, University of Sarajevo, in a 6-month period (July - December 2015). The following data were obtained: age, gender, reason for admission, Simplified Acute Physiology Score II, Acute Physiology and Chronic Health Evaluation, lactate concentrations upon admission, after 24 and 48 hours, and outcome (discharge from hospital or death).

resultsUpon admission,hyperlactatemia was present in 91.4% patients with a mean concentration of lactate 4.13 ±1.21 mmol/L. Lactate concentration at 48 hours was independently associated within creased in-hospital mortality (P = 0.018).

conclusionPersistent hyperlactatemia is associated with adverse outcome in critically ill patients. Lactate concentration at 48 hours is independently associated within creased in-hospital mortality and it represents a statistically significant predictive marker of fatal outcomes of patients. Blood lactate concentrations > 2.25 mmol/L should be used by clinicians to identify patients at higher risk of death.

Indexed as

Critical IllnessAdultAgedAged, 80 and overBosnia and HerzegovinaFemaleHospital MortalityHumansHyperlactatemiaIntensive Care UnitsLactic AcidMaleMiddle AgedPrevalenceTime FactorsLactic Acidcritical illnessesfatal outcomeshyperlactatemia

Identifiers

PMID29416200
PMCPMC5770196
OpenAlexW2771943274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.